White label ELPA - ClinicalTrials.eu

Study on Sirolimus for Adults with Facial Skin Sarcoidosis: Evaluating Treatment for Moderate to Severe Cases

Not recruiting

2 1 1 1
Investigated diseases:
- Cutaneous sarcoidosis
Investigated drugs:
- Sirolimus
Study of Ruxolitinib for Patients with High-Risk Polycythemia Vera or High-Risk Essential Thrombocythemia

Not recruiting

2 1 1 1
Investigated diseases:
- Polycythaemia vera
- Essential thrombocythaemia
Investigated drugs:
- Ruxolitinib
Study on MK-0616, Ezetimibe, and Bempedoic Acid for Adults with High Cholesterol

Not recruiting

3 1 1
Investigated diseases:
- Hypercholesterolaemia
Investigated drugs:
Long-term Safety Study of Dasiglucagon for Children with Congenital Hyperinsulinism

Not recruiting

3 1 1
Investigated drugs:
- Dasiglucagon
Study on the Effects of Riociguat for Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension

Not recruiting

3 1 1
Investigated drugs:
- Riociguat
Study on Repeated Corticosteroid Injections with Methylprednisolone Acetate and Sodium Chloride for Patients with Chronic Cluster Headache

Not recruiting

3 1 1
Investigated diseases:
- Cluster headache
Investigated drugs:
- Methylprednisolone Acetate
- Sodium Chloride
Study on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Moderate to Severe Hidradenitis Suppurativa

Not recruiting

3 1 1
Investigated diseases:
- Hidradenitis
Investigated drugs:
- Bimekizumab
+3
Study of Adagloxad Simolenin/OBI-821, Capecitabine, and Pembrolizumab for Patients with High-Risk, Early-Stage Triple Negative Breast Cancer

Not recruiting

3 1 1 1
Investigated diseases:
- Triple negative breast cancer
Investigated drugs:
Study on the Effectiveness and Safety of Regorafenib for Patients with Metastatic Bone Sarcomas

Not recruiting

2 1 1 1
Investigated diseases:
Investigated drugs:
- Regorafenib
Study on Ceralasertib and Trastuzumab Deruxtecan for Patients with Non-Small Cell Lung Cancer After Anti-PD-1/PD-L1 Therapy

Not recruiting

4 1 1 1
Investigated diseases:
- Non-small cell lung cancer metastatic
Investigated drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies